Viola od Homeopathic Medicine Recall for Failed Identity Testing
Washington Homeopathic Products is recalling Viola od 6X and 30X homeopathic pills (Lot #29057) distributed nationwide due to out-of-specification results in identity testing using HPTLC analysis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a failed identity test result with no reported illnesses or injuries stated in the source. The hazard is a quality/identification control failure in a homeopathic product with no evidence of harm, falling under the Moderate category for quality-control or labeling-related issues without demonstrated injury.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Viola od 6X, 30X, Bee Stings homeopathic medicine pills packaged in multiple formats (4 Dram, 2 oz) with UPCs 740640501399, 740640501412, and 740640501498. The recall was initiated because testing using HPTLC (High-Performance Thin Layer Chromatography) analysis yielded out-of-specification results for identification testing.
The affected product is Lot #29057 with expiration date 8/17/2026. Distribution was nationwide in the USA. The recalled product is manufactured and distributed by Washington Homeopathic Products, Inc., located in Berkeley Springs, West Virginia.
Consumers who have purchased this product should stop using it and contact the manufacturer or their healthcare provider with questions about safe disposal or potential health concerns.
The recalled product
- Product
- Viola od 6X, 30X, Bee Stings*, Sucrose/Lactose Pills, 6X Packaged in a) 4 Dram, UPC 7 40640 50139 9; 30X Packaged in b) 4 dr, UPC 7 40640 50141 2; c) 2 oz, UPC 7 40640 50149 8; WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- failed-identity-testing
- out-of-specification-results
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29057
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27